A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
Clinical trial NCT07416604 · RECRUITING
Trial details
- NCT number
- NCT07416604
- Sponsor
- Hoffmann-La Roche
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-27
- Primary completion
- 2028-02-29
- Enrollment
- 360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.